«Artificial intelligence is making rapid inroads in helping with the discovery of potential medicines.

In the latest example, a Hong Kong–based biotechnology company, Insilico Medicine, which uses A.I. tools to help it find potential new therapies, announced Tuesday it has brought a drug candidate from an initial scientific hunch to the cusp of human clinical trials in less than 18 months, a time span the company says may be a new record for a process that often takes more than four years.»

Article written by JEREMY KAHN